Plné znění - 2/2008 Sb. m. s.

Ministerstvo zahraničních xxxx xxxxxxx, xx xxx 16. xxxxxxxxx 2007 xxxx xxxxxxxxxx xxxxxxxxx UNESCO, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx xxxxx x metod dopingu.

Xxxxxxx I vstoupila x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Xxxxxx xxx 1. ledna 2008 x tímto xxxx xxxxxxxxx x xxxxxxxx i xxx Xxxxxx xxxxxxxxx. Dnem xxxxxx Xxxxxxx X x xxxxxxxx xxxxxxxx xxxxxx Xxxxxxx I Xxxxxxxxxxx úmluvy xxxxx xxxxxxx ve sportu xx xxxxx xxx xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. x.

Xxxxxxxx xxxxx Xxxxxxx X x xxxx xxxxxxx xx xxxxxxx xxxxxx xx xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX XXXXX

Xxxxxxxxxx xxxxx jsou xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (XXX):

x. Exogenní * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-androstendion (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); xxxxxxxxxx; xxxxxxxx; boldion (androsta-1,4-dien-3,17-dion); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; ethylestrenol (19-nor-17α-pregn-4-en-17-ol); xxxxxxxxxxxxxx; formebolon; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-hydroxytestosteron (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; xxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; metandienon (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; methandriol; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9,11-trien-3-on); methyltestosteron; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); norboleton; xxxxxxxxxxxxxx; xxxxxxxxxxxx; oxabolon; oxandrolon; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; xxxxxxxxxx; xxxxxxxxx; 1-xxxxxxxxxxx (17β-hydroxy-5α-androst-1-en-3-on); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); trenbolon x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

b. Xxxxxxxxx ** AAS:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, DHEA), xxxxxxxxxxx x xxxxxxxxxxx metabolity x xxxxxxx:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

androst-5-en-3α,17α-diol 19-noretiocholanolon

xxxxxxx-5-xx-3α,17β-xxxx

V xxxxxxxxx, xxx xxxx xxxx xxxxxxxxxx androgenní xxxxxxxxxx xxxxxxx xxxxxxxxx, xxxx xx xxx xx to, xx Xxxxxx xxxxxxxx tuto Xxxxxxxxx xxxxx x xxxx xxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx xx xxxxxxxxxxx Xxxxxxxx látky nebo xxxxxx xxxxxxxxxx xxxx xxxxxxxxxxx x/xxxx xxxx xx xxxxxxxx xxxx xxxxxxxxx xxxxx xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx xxxxxx, které se xxxxxxxx vyskytují x xxxx xxx, xx xxxxxxxxxx normální endogenní xxxxxxxx. Xxxxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxx případě, xxxxx Xxxxxxxxx xxxxxxx, že xx koncentrace Zakázané xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx xxxxxxxxx poměr xx Xxxxxx Xxxxxxxxx xxxxxxxx fyziologickým nebo xxxxxxxxxxxx xxxxxx.

Xxxx xx xxx xx xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx ve xxxxx xxxxxxxxx a xxx xxxxxxxxx xxxxxxxxxxx, xxxxx xxx podle xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxx, xx xx Zakázaná látka xxxxxxxxxx původu. X xxxxxxx xxxxxxx není xxxxx xxxxxxxx další xxxxxxx.

Xxxx se xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx xx xxxxxxx xxxxxx, které xx xxxxxxxx xxxxxxxxx x lidí a xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx původ Xxxxxxxx xxxxx, ale xxxxxxxx známky xxxxxxx Xxxxxxxx látky, xxxx xxxx. xxxxxxxxx x xxxxxxxxxxx referenčními steroidními xxxxxxx, xxxx xxxx xxxxxxxxx xxxxxxxxx xxxxx X/X vyšší xxx xxxxx (4) xx xxxxx (1) x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx, provede xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxx porovnáním xxxxxxxx xxxxxxxxxx testů nebo xxxxxxxxxx xxxxxxxxxx testů.

Xx-xx vyžadováno xxxxxx xxxxx šetření, xxx xxxxxxxx xxxx xxxxxxxxxx xxxxxx xxxx xxxxxxxxx x ne xxxx xxxxxxxxx. Pokud xxxxxxxxx xxxxxxx, xx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx xxxxx xxxxxxxx xxxxx šetření, x xxxx se xxx xx to, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx. Xxxxx xxxxxx xxxxxxx xxxxxxxxxx analytická xxxxxx (xxxx. XXXX) x xxxxxx x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx xxxxx, xxxx xxxxxxx longitudinální xxxxxx Xxxxxxxxx xxx, že xxxx příslušnou Antidopingovou xxxxxxxxxx x xxxxxxxxxxxxx 3 xxxxxxxx xxxxxxx xxxxxxxx bez xxxxxxxxxxx xxxxxxxx. Xxxxxxxx, xxxxx xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, xxxx hlášen xxxx xxxxxxxxx. Xxxxx xxxxxxxxxxxxxx profil Sportovce, xxxxxxxx xxxxxxxxxx xxxxx, xxxx fyziologicky xxxxxxxx, xxxx xx xxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx nález.

X xxxxxxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx xxxx být x moči xxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx xx xxxxxx xxxxxx xxxxxxxxxxxxx (ng/ml). Xxxxx laboratoř xxxxxx xxxxx nahlásila x xxxxxxx xxxxxxxxxx analytické xxxxxx (xxxx. IRMS) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx xxx provedeno xxxxx xxxxxxx provedením xxxxxxxxxx xxxxx (následných xxxxx).

Xxxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx 19-xxxxxxxxxxxxxxx, xxxx xx xx xxxxxxxxx xx xxxxxxx x xxxxxxxxxxx xxxxx exogenního původu Xxxxxxxx xxxxx. V xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

X xxxxxxx, xx Xxxxxxxxx xxxxxx xxxxxxxxxxxxx xxx dalších xxxxxxxxx, xxxx xx xxx xx xx, xx Vzorek Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx.

2. Ostatní xxxxxxxxxx xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SARM), xxxxxxx, xxxxxxx, xxxxxxxxxx, ale xx x omezením xxxxx xx xx.

S2. XXXXXXX X PŘÍBUZNÉ XXXXX

Následující xxxxx x jejich xxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Xxxxxxxxxxxx (EPO);

2. Xxxxxxx xxxxxx (xXX), xxxxxxxx xxxxxxx xxxxxxx xxxxxxx (xxxx. XXX-1), mechanické xxxxxxx xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (xxxx. XX, xXX), xxxxxxxx jen x xxxx;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

Pokud Xxxxxxxxx xxxxxx xxxxxxxx, xx koncentrace xxxx xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx xxxxxx, bude xx xxx za xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx (xxx xx uvedeno xxxx) v xxxxxxxxx, xxx koncentrace Zakázané xxxxx xxxx xxxxxx xxxxxxxxxx či xxxxxxxxxx x/xxxx xxxxxxxxx xxxxxx xx Xxxxxx Xxxxxxxxx xxxxxxx překročí hodnoty xxxxxxxx xxxxxxxx x xxxx xxx, xx xxxxxxxxxxxx normální xxxxxxxxx xxxxxxxx.

Pokud xxxxxxxxx xxxxxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxxxx metody, xx Zakázaná xxxxx xx xxxxxxxxxx původu, xxxx xx xxx xx xx, xx Xxxxxx obsahuje Zakázanou xxxxx x bude xxxxxxx Pozitivní xxxxxxxxxxx xxxxx.

X3. XXXX-2 XXXXXXXX

Xxxxxxx xxxx-2 xxxxxxxx včetně xxxxxx D- x X-xxxxxxx xxxx zakázáni.

Xxxxxxxx jsou xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxx, xxx xxxxx xx při inhalaci xxxxx xxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxxx.

X xxxx xxxx udělena xxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxx, xxxx xxxxx xxxxxxxxxxx (xxxxx plus xxxxxxxxxx) vyšší xxx 1000 xxxxxxxxx v 1 mililitru xxxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx Xxxxxxxxx neprokáže, že xxxxxxxxxx výsledek xxx xxxxxxxx xxxxxxxxxxxxx užíváním xxxxxxxxxxx x inhalaci.

S4. XXXXXXXXXXX X MODULÁTORY XXXXXXX

Xxxxxxxxxxx skupiny xxxx xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

2. Selektivní modulátory xxxxxxxxxxxxx receptorů (SERM), xxxxxxxx:

3. Xxxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxx inhibitorů xxxxxxxxxx, ale xx x xxxxxxxx xxxxx xx xx.

X5. XXXXXXXXX X XXXXXXX MASKOVACÍ XXXXX

Xxxxxxxxx xxxxx xxxx zakázané. Xxxxxxxx:

Xxxxxxxxx*, epitestosteron, probenecid, xxxxxxxxxx alfa-reduktázy (xxxx. xxxxxxxxxx, xxxxxxxxxx), xxxxxxxxxxxxxxx (xxxx. xxxxxxx, xxxxxxx, xxxxxxxxxxxxxxxxx) a xxxxx xxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, furosemid, xxxxxxxxxxxx, xxxxxxxxx, kanrenon, kyselina xxxxxxxxxx, xxxxxxxxx, spironolakton, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), xxxxxxxxxx x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx (kromě xxxxxxxxxxxx, xxxxx není xxxxxxxx).

* Terapeutická xxxxxxx není xxxxxx, xxxxx xxx Sportovce xxxxxxxx xxxxxxxxx xx xxxxxxx x prahovou xxxx xxxxxxxxxxx xxxxxxxx xxxx Xxxxxxxx látky (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Zakázané xx xxxxxxxxxxx:

X2. XXXXXXXX X XXXXXXXXX MANIPULACE

X3. XXXXXX XXXXXX

Xxxxxxxxxxxxxx xxxxxxx xxxxx, xxxx, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx xxxxxxx genů, xxxxx xxxx schopnost xxxxxx xxxxxxxxx výkon, xx zakázané.

X6. STIMULANCIA

Xxxxxxx xxxxxxxxxxx (xxxxxx xxxx xxxxxx xxxxxxxxxx optických (X- x X-) xxxxxxx) jsou xxxxxxxx, x xxxxxxxx derivátů xxxxxxxxx x případě xxxxxx xxxxxxxx xxxxx x stimulancií xxxxxxxxxx xx Xxxxxxxxxxxxxx xxxxxxxx xxx rok 2008.

Xxxxxxxxxxx zahrnují:

Xxxxxxxxx, xxxxxxxxx**, xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxx, amfetamin, xxxxxxxxxxx, xxxxxxxxxxxxxxx, bromantan, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, efedrin****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, fenkamin, xxxxxxxxxxx, fenprometamin, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (karfedon), xxxxxxxxxx, heptaminol, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, krotetamid, levmetamfetamin, xxxxxxxxx, xxxxxxxxxxx, meklofenoxát, xxxxxxxxxxxx (D-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, modafinil, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxx, oktopamin, xxxxxxxxx, oxilofrin, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, propylhexedrin, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx výslovně xxxx příklady x xxxxx oddíle xxxx xxxxxxxxxx xx specifickou xxxxx pouze, xxxxx Xxxxxxxxx xxxxxxx, že xxxx xxxxxxxxx xxxxxxxxxx x běžných léčebných xxxxxxxxxxx xxxxxxxx neúmyslné xxxxxxxx antidopingových pravidel, xxxx xx x xxx xxxxx pravděpodobnost, xx bude úspěšně xxxxxxxx xxxx xxxxxxxxx xxxxx.

X7. XXXXXXXXX

Následující xxxxxxxxx xxxx zakázaná:

Xxxxxxxxxxx, xxxxxxxxxxxxx, diamorfin(heroin), xxxxxxxx x xxxx xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, oxymorfon, pentazocin, xxxxxxx.

X8. XXXXXXXXXXX

Xxxxxxxxxxx (xxxx. xxxxx, xxxxxxxxx) xxxx xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx orálně, rektálně, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx xxxx zakázané. Xxxxxx užití xxxxxxxx xxxxxxxxxxxxx výjimku.

Xxxx xxxxxxx xxxxxxxx xxxxxxxx (xxxxxxxxxxxx, xx xxxxx xxxxxx, xx xxxxx xxxxxx, epidurální, xx xxxx) x xxxxxxxxx xxxxxxxx vyžadují xxxxxxxxx xxxxxxxxxxxxx výjimku x xxxxxxxx níže xxxxxxxxx.

Xxxxxxx xxxxxxxxx xxxxxxxx xx potíže xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), xxxx, xxxxx, oční, xxxxxx xxxxx xxxxxxx otvoru, xxxxxxxx xxx a xxxxx xxxxxx xxxxxxxx x xxxxxxxxxx xxxxxx xxxxx terapeutické xxxxxxx.

X1. XXXXXXX

Xxxxxxx (etanol) xx zakázaný pouze Xxx soutěži x xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx xxxxxxxx xxxxxxxx xxxxxxxx a/nebo xxxxxxxx xxxx. Prahová xxxxxxx xxx porušení xxxxxxxxxxx xxxxxxxx (hematologická xxxxxxx) xx pro xxxxxx xxxxxxxx xxxxxxx x xxxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (XXX) (0.10 g/l)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx a xxxxxxxxxxxx (XXX) (0.20 g/l)

∙ Lukostřelba (XXXX, XXX) (0.10 x/x)

∙ Moderní xxxxxxx (XXXX) jen pro xxxxxxxxxx xx xxxxxxxx (0.10 g/l)

∙ Xxxxxxxxxxx xxxxx (XXX) (0.10 g/l)

∙ Xxxxx xxxxxxxxxx (XXX) (0.30 x/x)

∙ Kuželky (XXX) (0.10 g/l)

X2. XXXX-XXXXXXXXX

Pokud xxxx xxxxx určeno, xxxx-xxxxxxxxx jsou zakázány xxxxx Při xxxxxxx x xxxxxxxxxxxxx sportech.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx (XXXX)

∙ Boby (XXXX)

∙ Bridž (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Jachting (XXXX) - "xxxxx xxxx" - xxx xxxxxxxxxxx

∙ Kuželky (XXX)

∙ Letecké xxxxxx x xxxxxxxxxxxx (XXX)

∙ Lukostřelba (XXXX, IPC) (xxxxxxxx xxxx Xxxx soutěž)

∙ Lyžování (FIS) - xxxxx na xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx a X-xxxxx, x snowboard U-rampa x "xxx air"

∙ Moderní xxxxxxx (XXXX) - jen xxxxxxxxxx xx střelbou

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx x xxxxxxx xxxxxx (XXXX, IPC "xxxxx")

∙ Střelba (XXXX, XXX) (xxxxxxxx také Xxxx xxxxxx)

∙ Xxxxx xxxxxxxxxx (XXX)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx xxxxxxxx následující xxxxx:

Acebutolol, alprenolol, xxxxxxxx, xxxxxxxxx, bisoprolol, xxxxxxx, celiprolol, xxxxxxx, xxxxxxxxx, karvedilol, labetalol, xxxxxxxxxxx, metipranolol, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, pindolol, xxxxxxxxxxx, xxxxxxx, timolol, xxx xx s xxxxxxxx pouze xx xx

"Xxxxxxxxxx látky"* xxxx xxxxxxxxxxx níže:

∙ Xxxxxxx Xxxx-2 xxxxxxxx v xxxxxxxx, xxxxx salbutamolu (xxxxxxx xxxx xxxxxxxxxxx) xxx xxxxxxxx větším xxx 1000 xx/xx xxxx x xxxxxxxxxxxx (xxxxxxx xx xxxxxxx S 1.2 Ostatní xxxxxxxxxx xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, haptaminol, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, p-metylamfetamin, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, sibutramin, xxxxxxxxxxxxx x všechna xxxxxxx xxxxxxxxxxx neuvedená xxxxxxxx v xxxxxx X6, pro která Xxxxxxxxx prokáže, xx xxxxxxx podmínky popsané x xxxxxx X6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxxxxx látky, xxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx jsou všeobecně xxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx, nebo x xxxxx xx xxxxx xxxxxxxxxxxxxxx, xx xxxxx úspěšně zneužity xxxx xxxxxxxxx činidla." Xxxxxxxx antidopingového pravidla xxxxxxxxxx xxxxxxxx xxxxx xxxx xxxxxxxx xxxxxxx xxxxxx xx xxxxxxxxxxx, xx "...Sportovec xxxx xxxxx xxxxxxxx, že Xxxxxxx specifické xxxxx xxxxxx zamýšleno xx xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx xxxxxxx x. 2/2008 Sb. x. x. xxxxx xxxxxxxxx xxxx 31.1.2008.

Xxxxxx xxxxxxx x. 2/2008 Xx. x. x. byl xxxxxx xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x účinností xx 7.2.2009.

Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx x odkazech xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx uvedeného xxxxxxxx předpisu.